Intranasal delivery in glioblastoma treatment: prospective molecular treatment modalities

Glioblastoma multiforme (GBM) is rare and fatal glioma with limited treatment options. Treatments provide minimal improvement in prognosis and only 6.8% of GBM patients have a life expectancy greater than five years. Surgical resection of this malignant glioma is difficult due to its highly invasive...

Descripción completa

Detalles Bibliográficos
Autores principales: Morales, Daniel E., Mousa, Shaker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136349/
https://www.ncbi.nlm.nih.gov/pubmed/35647354
http://dx.doi.org/10.1016/j.heliyon.2022.e09517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136349/
https://www.ncbi.nlm.nih.gov/pubmed/35647354
http://dx.doi.org/10.1016/j.heliyon.2022.e09517

Ejemplares similares